Celsion Corporation logo
Celsion Corporation CLSN

Annual report 2025
added 03-31-2026

report update icon

Celsion Corporation Historical Prices 2011-2026 | CLSN

Annual Historical Prices Celsion Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 1.83 1.83 1.83 4.8 30.9 15.6 33.5 32.1 46.2 258 607 783 927 1.95 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.95 K 1.83 335

Historical Prices of other stocks in the Biotechnology industry

Issuer Historical Prices Price % 24h Market Cap Country
Amgen Amgen
AMGN
369 $ 350.13 2.98 % $ 188 B usaUSA
MorphoSys AG MorphoSys AG
MOR
18.2 - 2.43 % $ 254 M germanyGermany
Acorda Therapeutics Acorda Therapeutics
ACOR
13.5 - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
3.86 - - $ 86.2 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
13.8 $ 12.73 3.33 % $ 3.99 B usaUSA
AlloVir AlloVir
ALVR
9.78 - 4.14 % $ 49.1 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
0.57 - - $ 10.1 M usaUSA
argenx SE argenx SE
ARGX
691 $ 783.17 2.32 % $ 25 B niderlandNiderland
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
1.21 $ 1.48 8.82 % $ 394 M britainBritain
Applied Therapeutics Applied Therapeutics
APLT
6.42 - - $ 8.42 M usaUSA
I-Mab I-Mab
IMAB
0.68 - - $ 866 M chinaChina
Genfit SA Genfit SA
GNFT
3.36 - 2.54 % $ 160 B franceFrance
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
27.1 $ 24.57 5.59 % $ 3.13 B usaUSA
Biophytis SA Biophytis SA
BPTS
0.33 - -13.47 % $ 169 M franceFrance
AVROBIO AVROBIO
AVRO
1.27 - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
0.5 - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
74.2 - - $ 96.9 B britainBritain
Midatech Pharma plc Midatech Pharma plc
MTP
0.29 - -18.52 % $ 27.3 M britainBritain
BioNTech SE BioNTech SE
BNTX
91.2 $ 91.64 2.25 % $ 27.2 B germanyGermany
BeiGene, Ltd. BeiGene, Ltd.
BGNE
185 - 0.49 % $ 251 B cayman-islandsCayman-islands
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
0.58 $ 3.82 1.6 % $ 9.19 B australiaAustralia
Burford Capital Limited Burford Capital Limited
BUR
10.6 $ 4.62 1.54 % $ 742 M britainBritain
CymaBay Therapeutics CymaBay Therapeutics
CBAY
32.3 - - $ 3.45 B usaUSA
Advaxis Advaxis
ADXS
0.31 - -9.65 % $ 45.9 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
2.51 $ 2.68 4.28 % $ 16.8 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
6.7 - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
23.4 - - $ 1.41 B usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
1.45 $ 3.05 0.66 % $ 6.64 B israelIsrael
Cabaletta Bio Cabaletta Bio
CABA
2.82 $ 3.05 -0.5 % $ 306 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
4.04 - - $ 169 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
5.72 - 5.93 % $ 314 M canadaCanada
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
2.44 - - $ 231 M usaUSA
Cerus Corporation Cerus Corporation
CERS
2.6 $ 1.93 4.62 % $ 368 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
13 - -10.17 % $ 12.2 K usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
3.03 - - $ 401 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
12 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.3 - - $ 26.5 M usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
4.8 - - $ 1.2 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.17 - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
3.32 - -45.71 % $ 1.2 M canadaCanada
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
4.9 - -4.36 % $ 27 M usaUSA
Cellectar Biosciences Cellectar Biosciences
CLRB
2.87 $ 2.83 2.91 % $ 7.38 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
14.1 - - $ 2.18 B usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
48.4 - - $ 3.67 B usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
13.3 - - $ 2.02 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
19.3 - - $ 867 M germanyGermany
Coherus BioSciences Coherus BioSciences
CHRS
1.93 $ 1.73 3.59 % $ 203 M usaUSA